• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

松鼠猴(松鼠猴属)中的血管加压素拮抗作用。

Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).

作者信息

Kinter L B, Churchill S, Stassen F L, Moore M, Huffman W

出版信息

J Pharmacol Exp Ther. 1987 Jun;241(3):797-803.

PMID:3598903
Abstract

Vasopressin antagonism and water diuresis (aquaresis) is demonstrated after i.p. or i.v. administration of vasopressin antagonists in a primate species, the squirrel monkey (Saimiri sciureus). Antagonism of vasopressin-stimulated renal medullary adenylate cyclase activity was evaluated in vitro; the most potent antagonists were those with D-tyrosine (alkyl) substitutions at position 2. Aquaresis was evaluated in vivo; the most potent aquaretic agents were again those with D-tyrosine (alkyl) substitutions at position 2. Correlation of in vitro vasopressin antagonist and in vivo aquaretic potencies for a series of antagonists was r = 0.7880 (P less than .05). Renal excretion of electrolytes, creatinine and urea tended to increase slightly as a function of vasopressin antagonist dose; the rates of solute excretion approached but seldom exceeded those rates associated with water diuresis in squirrel monkeys. The vasopressin antagonists antagonized the antidiuretic activity of exogenous vasopressin in vivo. Onset of the aquaretic response to i.v. administration of desGlyd(CH2)5D-Tyr(Et)VAVP was within 30 min; duration was greater than 120 min. These studies establish vasopressin antagonism and aquaresis associated with administration of vasopressin antagonists in a primate species.

摘要

在松鼠猴(Saimiri sciureus)这一灵长类动物中,腹腔注射或静脉注射加压素拮抗剂后,可观察到加压素拮抗作用和水利尿(水清除)现象。在体外评估了加压素刺激的肾髓质腺苷酸环化酶活性的拮抗作用;最有效的拮抗剂是在第2位具有D-酪氨酸(烷基)取代的那些。在体内评估了水清除作用;最有效的利水剂同样是在第2位具有D-酪氨酸(烷基)取代的那些。一系列拮抗剂的体外加压素拮抗剂活性与体内利水活性之间的相关性为r = 0.7880(P小于0.05)。随着加压素拮抗剂剂量的增加,电解质、肌酐和尿素的肾排泄量略有增加的趋势;溶质排泄率接近但很少超过松鼠猴中与水利尿相关的排泄率。加压素拮抗剂在体内拮抗外源性加压素的抗利尿活性。静脉注射去甘氨酰(CH2)5D-酪氨酸(乙基)加压素(desGlyd(CH2)5D-Tyr(Et)VAVP)后,利水反应的起效时间在30分钟内;持续时间超过120分钟。这些研究证实了在灵长类动物中与加压素拮抗剂给药相关的加压素拮抗作用和水清除作用。

相似文献

1
Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).松鼠猴(松鼠猴属)中的血管加压素拮抗作用。
J Pharmacol Exp Ther. 1987 Jun;241(3):797-803.
2
SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).SK&F 105494是恒河猴(猕猴)体内一种有效的抗利尿激素拮抗剂。
J Pharmacol Exp Ther. 1988 Apr;245(1):211-5.
3
Discovery and therapeutic utility of vasopressin antagonists in rats.血管加压素拮抗剂在大鼠中的发现及其治疗用途
J Cardiovasc Pharmacol. 1986;8 Suppl 7:S36-43. doi: 10.1097/00005344-198600087-00008.
4
Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.抗利尿激素拮抗剂与犬的水清除:肾皮质和肾乳头中不同的血管加压素敏感性和拮抗剂效力
J Pharmacol Exp Ther. 1985 Jan;232(1):100-5.
5
Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney.新型抗利尿拮抗剂的分子机制:对动物和人类肾脏中血管加压素结合及腺苷酸环化酶激活作用的分析
J Pharmacol Exp Ther. 1982 Oct;223(1):50-4.
6
Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
Acta Med Hung. 1984;41(1):65-73.
7
Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.对大鼠长期给予抗利尿激素拮抗剂后,肾腺苷酸环化酶偶联抗利尿激素受体上调。
J Pharmacol Exp Ther. 1991 Sep;258(3):1046-54.
8
Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
Biochem Biophys Res Commun. 1987 Apr 29;144(2):770-8. doi: 10.1016/s0006-291x(87)80031-1.
9
An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.探索L-和D-四氢异喹啉-3-羧酸取代在血管加压素和催产素的环状和线性拮抗剂的2、3和7位以及精氨酸血管加压素的3位的作用。
J Pept Sci. 1995 Jan-Feb;1(1):66-79. doi: 10.1002/psc.310010109.
10
Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.氯磺丙脲增强1-去氨基-8-D-精氨酸加压素诱导的抗利尿作用,并刺激肾髓质腺苷酸环化酶及3',5'-环磷酸腺苷的蓄积。
Endocrinology. 1980 Mar;106(3):967-72. doi: 10.1210/endo-106-3-967.

引用本文的文献

1
Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin.蛛网膜下腔出血后的脑水肿。血管加压素的发病机制意义。
Acta Neurochir (Wien). 1995;133(3-4):122-33. doi: 10.1007/BF01420062.
2
Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.强效利水性药物。一种新型非肽类选择性血管加压素2拮抗剂(OPC - 31260)在男性中的应用。
J Clin Invest. 1993 Dec;92(6):2653-9. doi: 10.1172/JCI116881.
3
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.恒河猴对血管加压素肽的潮红和血流动力学反应。
Br J Pharmacol. 1988 Jul;94(3):759-64. doi: 10.1111/j.1476-5381.1988.tb11586.x.